Key statistics
As of last trade GoodRx Holdings Inc (GDRX:NSQ) traded at 2.26, 7.38% above its 52-week low of 2.10, set on Feb 03, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.31 |
|---|---|
| High | 2.33 |
| Low | 2.17 |
| Bid | 2.25 |
| Offer | 2.26 |
| Previous close | 2.33 |
| Average volume | 4.90m |
|---|---|
| Shares outstanding | 339.43m |
| Free float | 89.31m |
| P/E (TTM) | 25.80 |
| Market cap | 750.15m USD |
| EPS (TTM) | 0.0857 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 19:37 GMT.
More ▼
- GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
- GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
- GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
- Surescripts and GoodRx Partner to Advance Patient Price Transparency
- GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
- GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill
- GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
More ▼
